Agro Phos India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 7, 2025, 8:04 pm

Competitors of Agro Phos India Ltd

All Competitor Stocks of Agro Phos India Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:10 pm

Below is a detailed analysis of the quarterly data for Agro Phos India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 39.80 Cr.. The value appears strong and on an upward trend. It has increased from 30.11 Cr. (Mar 2025) to 39.80 Cr., marking an increase of 9.69 Cr..
• For Expenses, as of Jun 2025, the value is 31.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.21 Cr. (Mar 2025) to 31.87 Cr., marking an increase of 5.66 Cr..
• For Operating Profit, as of Jun 2025, the value is 7.93 Cr.. The value appears strong and on an upward trend. It has increased from 3.90 Cr. (Mar 2025) to 7.93 Cr., marking an increase of 4.03 Cr..
• For OPM %, as of Jun 2025, the value is 19.92%. The value appears strong and on an upward trend. It has increased from 12.95% (Mar 2025) to 19.92%, marking an increase of 6.97%.
• For Other Income, as of Jun 2025, the value is 0.09 Cr.. The value appears to be declining and may need further review. It has decreased from 0.31 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.22 Cr..
• For Interest, as of Jun 2025, the value is 1.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.08 Cr. (Mar 2025) to 1.14 Cr., marking an increase of 0.06 Cr..
• For Depreciation, as of Jun 2025, the value is 0.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.48 Cr. (Mar 2025) to 0.49 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 6.39 Cr.. The value appears strong and on an upward trend. It has increased from 2.65 Cr. (Mar 2025) to 6.39 Cr., marking an increase of 3.74 Cr..
• For Tax %, as of Jun 2025, the value is 32.86%. The value appears to be increasing, which may not be favorable. It has increased from 5.28% (Mar 2025) to 32.86%, marking an increase of 27.58%.
• For Net Profit, as of Jun 2025, the value is 4.29 Cr.. The value appears strong and on an upward trend. It has increased from 2.51 Cr. (Mar 2025) to 4.29 Cr., marking an increase of 1.78 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.12. The value appears strong and on an upward trend. It has increased from 1.24 (Mar 2025) to 2.12, marking an increase of 0.88.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:46 am

Growth

Last Updated: September 4, 2025, 10:25 pm

Balance Sheet

Last Updated: October 10, 2025, 1:34 pm

Below is a detailed analysis of the balance sheet data for Agro Phos India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2024) to 44.00 Cr., marking an increase of 5.00 Cr..
• For Borrowings, as of Mar 2025, the value is 28.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 29.00 Cr. (Mar 2024) to 28.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 64.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.00 Cr. (Mar 2024) to 64.00 Cr., marking an increase of 43.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 157.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 109.00 Cr. (Mar 2024) to 157.00 Cr., marking an increase of 48.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2024) to 23.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Other Assets, as of Mar 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Mar 2024) to 129.00 Cr., marking an increase of 49.00 Cr..
• For Total Assets, as of Mar 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 109.00 Cr. (Mar 2024) to 157.00 Cr., marking an increase of 48.00 Cr..

Notably, the Reserves (44.00 Cr.) exceed the Borrowings (28.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Agro Phos India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 5. It has increased from -2.59 (Mar 24) to 2.48, marking an increase of 5.07.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 5. It has increased from -2.59 (Mar 24) to 2.48, marking an increase of 5.07.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.55. This value is within the healthy range. It has increased from -1.74 (Mar 24) to 3.55, marking an increase of 5.29.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32.24. It has increased from 23.80 (Mar 24) to 32.24, marking an increase of 8.44.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32.24. It has increased from 23.80 (Mar 24) to 32.24, marking an increase of 8.44.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 59.13. It has increased from 52.85 (Mar 24) to 59.13, marking an increase of 6.28.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 7.34. This value is within the healthy range. It has increased from -1.00 (Mar 24) to 7.34, marking an increase of 8.34.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.38. This value is within the healthy range. It has increased from -1.86 (Mar 24) to 6.38, marking an increase of 8.24.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.49. This value is within the healthy range. It has increased from -3.54 (Mar 24) to 4.49, marking an increase of 8.03.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.59. This value is within the healthy range. It has increased from -2.59 (Mar 24) to 2.59, marking an increase of 5.18.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.48. This value is within the healthy range. It has increased from -2.60 (Mar 24) to 2.48, marking an increase of 5.08.
• For PBDIT Margin (%), as of Mar 25, the value is 12.41. This value is within the healthy range. It has increased from -1.90 (Mar 24) to 12.41, marking an increase of 14.31.
• For PBIT Margin (%), as of Mar 25, the value is 10.78. This value is within the healthy range. It has increased from -3.51 (Mar 24) to 10.78, marking an increase of 14.29.
• For PBT Margin (%), as of Mar 25, the value is 7.58. This value is below the healthy minimum of 10. It has increased from -6.70 (Mar 24) to 7.58, marking an increase of 14.28.
• For Net Profit Margin (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 5. It has increased from -4.90 (Mar 24) to 4.38, marking an increase of 9.28.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.20. This value is below the healthy minimum of 8. It has increased from -4.92 (Mar 24) to 4.20, marking an increase of 9.12.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.70. This value is below the healthy minimum of 15. It has increased from -10.93 (Mar 24) to 7.70, marking an increase of 18.63.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.84. This value is within the healthy range. It has increased from -7.48 (Mar 24) to 18.84, marking an increase of 26.32.
• For Return On Assets (%), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 5. It has increased from -5.34 (Mar 24) to 3.19, marking an increase of 8.53.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has decreased from 0.59 (Mar 24) to 0.43, marking a decrease of 0.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.93. It has increased from 0.00 (Mar 24) to 0.93, marking an increase of 0.93.
• For Current Ratio (X), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 1.5. It has increased from 1.40 (Mar 24) to 1.44, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.70 (Mar 24) to 0.79, marking an increase of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.99. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 1.99, marking an increase of 1.99.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from -0.59 (Mar 24) to 3.88, marking an increase of 4.47.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 3. It has increased from -0.53 (Mar 24) to 2.37, marking an increase of 2.90.
• For Enterprise Value (Cr.), as of Mar 25, the value is 85.08. It has decreased from 101.41 (Mar 24) to 85.08, marking a decrease of 16.33.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.70, marking a decrease of 0.24.
• For EV / EBITDA (X), as of Mar 25, the value is 5.72. This value is within the healthy range. It has increased from -49.80 (Mar 24) to 5.72, marking an increase of 55.52.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 24) to 0.48, marking a decrease of 0.20.
• For Price / BV (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 1.52 (Mar 24) to 0.88, marking a decrease of 0.64.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 24) to 0.48, marking a decrease of 0.20.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -0.07 (Mar 24) to 0.08, marking an increase of 0.15.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness